Aaron Glieberman

Aaron Glieberman currently serves as the Director of Platform Development at MelliCell, Inc., focusing on adapting cell assays for high throughput drug screening and overseeing the development of an automated data processing pipeline in Python. Prior to this role, Aaron was a Senior Engineer in Platform Development at Harvard University and worked on continuous hormone sensors, as well as organ-on-chip technology during graduate studies. Aaron’s extensive experience includes positions at Fraunhofer USA and MIT, where research efforts spanned lab-on-a-chip devices and synthetic biology, complemented by a background in emergency medical response and health and safety instruction. Aaron holds a PhD in Engineering Sciences from Harvard University, along with degrees in Biomedical Engineering from Brown University.